{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
MetLife, Inc. Experiences Valuation Adjustment Amid Competitive Insurance Market Dynamics
MetLife, Inc. has recently adjusted its valuation, with its stock price at $78.68. Over the past year, it has underperformed compared to the S&P 500. Key metrics include a P/E ratio of 18, a price-to-book value of 2.94, and a notable dividend yield of 204.59%.
MetLife, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape
MetLife, Inc. has recently adjusted its valuation, showcasing a competitive price-to-earnings ratio of 18 and a price-to-book value of 2.94. The company maintains a strong dividend yield and return on equity, while its long-term performance remains solid despite recent challenges compared to the broader market.
MetLife Stock Forms Golden Cross, Signaling Potential Bullish Breakout
MetLife, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The company's daily moving averages and weekly MACD are bullish, suggesting positive short-term performance. Despite a decline over the past year, MetLife has shown resilience with a notable one-day increase, outperforming the S&P 500.
MetLife, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape
MetLife, Inc. has recently adjusted its valuation, with its stock price at $82.37. Over the past year, it has returned 1.37%, underperforming the S&P 500. Key metrics include a P/E ratio of 18, a price-to-book value of 2.94, and a notable dividend yield of 204.59%.
Is MetLife, Inc. technically bullish or bearish?
As of September 9, 2025, MetLife, Inc. shows a mildly bullish technical trend, supported by a bullish weekly MACD and Bollinger Bands, despite mixed signals from other indicators and underperformance compared to the S&P 500 in the short term.
Is MetLife, Inc. overvalued or undervalued?
As of August 4, 2025, MetLife, Inc. is fairly valued with a P/E ratio of 18, a Price to Book Value of 2.94, and a PEG Ratio of 0.18, indicating potential growth, although it has underperformed the S&P 500 over the past three years with a return of 21.50%.
Is MetLife, Inc. technically bullish or bearish?
As of June 27, 2025, MetLife, Inc. shows a mildly bullish trend overall, supported by positive weekly indicators, though daily moving averages present a mildly bearish outlook, suggesting caution.
Is MetLife, Inc. overvalued or undervalued?
As of May 8, 2025, MetLife, Inc. is considered overvalued with a P/E ratio of 18 compared to the industry average of 24.36, despite a high dividend yield of 204.59% and recent stock performance that outpaced the S&P 500, indicating potential challenges in sustaining growth due to its expensive valuation.
Is MetLife, Inc. technically bullish or bearish?
As of June 20, 2025, MetLife, Inc. shows a neutral technical trend with mixed signals, as weekly indicators suggest mild bullishness while monthly indicators lean bearish, indicating a lack of clear direction.
Who are in the management team of MetLife, Inc.?
As of March 2022, MetLife, Inc.'s management team includes Dr. Robert Hubbard (Independent Chairman), Mr. Michel Khalaf (President and CEO), and several Independent Directors: Ms. Cheryl Grise, Mr. Carlos Gutierrez, Mr. Gerald Hassell, Mr. David Herzog, and Mr. Edward Kelly. They are responsible for the company's strategic direction and governance.
What does MetLife, Inc. do?
MetLife, Inc. is a large-cap provider of life insurance, annuities, employee benefits, and asset management. As of March 2025, it reported a net profit of $950 million and has a market cap of approximately $78.85 billion.
How big is MetLife, Inc.?
As of Jun 18, MetLife, Inc. has a market capitalization of $78.85 billion, with total assets of $677.46 billion and a consolidated net profit of $4.52 billion for the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
